# Evaluating the Effectiveness of Ondansetron Versus Dexamethasone Versus Placebo for the Control of Intraoperative Nausea and Vomiting in Patients Undergoing Lower-segment Caesarean Section Under Spinal Anesthesia

> **NCT05583214** · PHASE4 · UNKNOWN · sponsor: **Muhammad Mubariz** · enrollment: 90 (estimated)

## Conditions studied

- Caesarean Section
- Spinal Anesthesia

## Interventions

- **DRUG:** Ondansetron 8mg
- **DRUG:** Dexamethasone 8mg
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT05583214
- **Lead sponsor:** Muhammad Mubariz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10
- **Primary completion:** 2022-12
- **Final completion:** 2023-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2022-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05583214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05583214, "Evaluating the Effectiveness of Ondansetron Versus Dexamethasone Versus Placebo for the Control of Intraoperative Nausea and Vomiting in Patients Undergoing Lower-segment Caesarean Section Under Spinal Anesthesia". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05583214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*